Generic Threat

Published on: 

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-07-01-2001, Volume 0, Issue 0

Epsom, Surrey, United Kingdom—Pharmaceutical companies struggle to be taken seriously when they talk of facing pressures. A quick look at the bottom line often suggests they are overstating their worries. But new evidence shows they are being squeezed by generic competition and falling R&D output.